A Study of AMG 114 Administered by Subcutaneous Injection for the Treatment of Anemia in Subjects With Non-Myeloid Malignancies Receiving Multicycle Chemotherapy

A Study of Darbepoetin Alfa for the Treatment of Anemia in Subjects With a Non-Myeloid Malignancy

NCT00117624 ·Status: COMPLETED ·Phase: PHASE3

Treatment for Elderly Patients With High Risk Breast Cancer

NCT00117910 ·Status: COMPLETED ·Phase: PHASE3

Darbepoetin Alfa With or Without Intravenous (IV) Iron

NCT00401544 ·Status: COMPLETED ·Phase: PHASE2

Chemotherapy Related Anemia in Patients With Non-Myeloid Malignancies

NCT00036023 ·Status: COMPLETED ·Phase: PHASE2

Fractionated Dosing Study: Study to Evaluate Darbepoetin Alfa for the Treatment of Anemia in Subjects With Non-Myeloid Malignancies

NCT00239239 ·Status: COMPLETED ·Phase: PHASE2

PG2 Phase I/II Clinical Study Intravenously Administered in Patients With Advanced Malignancy

NCT01696565 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Treatment for Anemic Subjects With Non-Myeloid Malignancies Receiving Chemotherapy

NCT00120705 ·Status: COMPLETED ·Phase: PHASE2

A Study to Assess Symptom Burden in Subjects With Nonmyeloid Malignancies Receiving Chemotherapy and Aranesp®

NCT00117117 ·Status: COMPLETED ·Phase: PHASE4

A Dose-escalation Study of the Safety and Tolerability of Orally Administered TG101348 in Patients With Myelofibrosis

NCT00631462 ·Status: COMPLETED ·Phase: PHASE1

Treatment for Patients With Non-Myeloid Malignancies Receiving Chemotherapy

NCT00111137 ·Status: COMPLETED ·Phase: PHASE3

Study of Subcutaneously Administered Peginesatide in Anemic Cancer Patients Receiving Chemotherapy

NCT00272662 ·Status: COMPLETED ·Phase: PHASE2

Dose Finding Study of KRN125 (Pegfilgrastim) for Treatment of Neutropenic Patients

NCT00364468 ·Status: COMPLETED ·Phase: PHASE2

Bioequivalence Study of 6-Mercaptopurine Under Fasting Conditions

NCT00602134 ·Status: COMPLETED ·Phase: NA

Study of the Safety and Leukostimulatory Activity of the Preparation "Panagen" in Patients With Breast Cancer

NCT02115984 ·Status: COMPLETED ·Phase: PHASE2

FIRST - Study of Pegfilgrastim Administered in the First and Subsequent Cycles of Myelosuppressive Chemotherapy

NCT00125723 ·Status: COMPLETED ·Phase: PHASE4

Chemotherapy Administered Every 2 Weeks With or Without Pegfilgrastim in Subjects With Advanced or Metastatic Colon Cancer

NCT00094809 ·Status: COMPLETED ·Phase: PHASE2

Telpegfilgrastim Injection to Reduce the Risk of Neutropenia in Patients With Solid Tumor

NCT07096479 ·Status: RECRUITING

Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy

NCT00858364 ·Status: TERMINATED ·Phase: PHASE3

A Phase II, Dose-finding Study of F-627 in Patients With Breast Cancer Receiving Myelotoxic Chemotherapy.

NCT02521441 ·Status: COMPLETED ·Phase: PHASE2

Injection Regimen Trial of PEG-rhG-CSF During Breast Cancer Chemotherapy

NCT04477616 ·Status: COMPLETED ·Phase: PHASE2

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of YPEG-Filgrastim in Chemotherapy Patients

NCT01238562 ·Status: COMPLETED ·Phase: PHASE1

Study to Assess the Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of GW003 in Patients With Breast Cancer

NCT02725606 ·Status: UNKNOWN ·Phase: PHASE1

A Study of Neutropenia and Anemia Management in Patients With Solid Tumors Receiving Myelotoxic Chemotherapy

NCT00883181 ·Status: COMPLETED

Nanogen Pegfilgrastim (Pegcyte) PK/PD Clinical Study in Breast Cancer Patients

NCT03376503 ·Status: COMPLETED ·Phase: PHASE1

A Study Comparing Pegylated Filgrastim and Filgrastim in Support for Chemotherapy

NCT01285219 ·Status: COMPLETED ·Phase: PHASE3